Diastolic Blood Pressure and Cognitive Function in Adults With Achieved Systolic Blood Pressure Below 130 mm Hg: Insights From the SPRINT-MIND Trial
Yang R, Fang Z, Yang D, Zhang L, Yang Q, Ling Q, et al.
Circulation: Cardiovascular Quality and Outcomes. Előzetes elektronikus közlés: 2025.10.10. https://doi.org/10.1161/CIRCOUTCOMES.124.011902
Differential Impacts of Resting and Exercise-Related Blood Pressure Changes on Cardiovascular and All-cause Mortalities
Dan-Ying Lee, Chi-Jung Huang, Chen-Huan Chen, Chern-En Chiang, Hao-Min Cheng, Shih-Hsien Sung
Amer J Hypertens. 2025; előzetes elektronikus közlés: 2025.10.08. hpaf184, https://doi.org/10.1093/ajh/hpaf184
Association of home blood pressure with asymptomatic Stage B heart failure determined by cardiac biomarkers.
Wachi, S., Narita, K., Fujiwara, T. et al.
Hypertens Res . 2025; 48:2654–2663. https://doi.org/10.1038/s41440-025-02305-w
Targeting a systolic blood pressure of <130 mmHg is beneficial in adults with hypertension aged ≥75 years: a systematic review and meta-analysis.
Nozato, Y., Nohara-Shitama, Y., Kubozono, T. et al.
Hypertens Res 2025; 48: 2527–2536 https://doi.org/10.1038/s41440-025-02302-z
Ambulatory blood pressure monitoring, European guideline targets, and cardiovascular outcomes: an individual patient data meta-analysis
Dong-Yan Zhang, De-Wei An, Yu-Ling Yu, Jesus D Melgarejo, José Boggia, Dries S Martens, et al. International Database of Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators, on behalf of
European Heart Journal, 2025; 46(30): 2974–2987, https://doi.org/10.1093/eurheartj/ehaf220
Prospective associations of daily step count and stepping intensity with overall and type-specific major adverse cardiovascular events in people with hypertension
Sonia W M Cheng, Raaj Kishore Biswas, Nicholas A Koemel, John F O’Sullivan, Angelo Sabag, Matthew N Ahmadi et al.
European Journal of Preventive Cardiology. Előzetes elektronikus közlés: 2025.08.06. https://doi.org/10.1093/eurjpc/zwaf441
Regional structural differences in the brain related to high blood pressure.
Rim D, Dawood T, Fatouleh R, McCarthy B, Sesa-Ashton G, Hennessy A, et al.
J Hypertens. 2025; 43(9):1570-1581. https://doi.org/10.1097/HJH.0000000000004091.
The effect of SGLT2 inhibitors on blood pressure in relation to baseline kidney function: A systematic literature review and data analysis
Charlotte Agergaard Møller, Steffen Flindt Nielsen, Frank Holden Mose,
American Journal of Hypertension. Előzetes elektronikus közlés: 2025.07.25. https://doi.org/10.1093/ajh/hpaf130
Comparison of Globorisk, SCORE2, and PREVENT in the Stratification of Cardiovascular Risk and its Relationship with End-Organ Damage Among Adults With Arterial Hypertension
Palomo-Piñón S, Alcocer L, Álvarez-López H, Cardona-Muñoz EG, Adolfo Chávez-Mendoza, Díaz-Díaz E, et al.
J Clin Hypertens. Előzetes elektronikus közlés: 2025.08.02. https://doi.org/10.1111/jch.70106
A Risk Stratification Model for Predicting Benefits of Intensive Blood Pressure Treatment: Analysis of the Systolic Blood Pressure Intervention Trial
Na Li, Zhixin Yang, Quan Yuan, Wenli Cheng
J Clin hypertens. Előzetes elektronikus közlés: 2025.08.02. https://doi.org/10.1111/jch.70098